-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ONFvOWpfhayAEKnh5NQFnjUc4gyTlEuuU20NsQ3xlirnDAgnr7TK4ypZWotsdkov LteC0SVH0p9VHCUeoWMseA== 0001005477-97-001054.txt : 19970415 0001005477-97-001054.hdr.sgml : 19970415 ACCESSION NUMBER: 0001005477-97-001054 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970414 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NOVITRON INTERNATIONAL INC CENTRAL INDEX KEY: 0000716646 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042573920 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-39041 FILM NUMBER: 97579648 BUSINESS ADDRESS: STREET 1: ONE GATEWAY CENTER STREET 2: SUITE 411 CITY: NEWTON STATE: MA ZIP: 02158 BUSINESS PHONE: 6172619933 MAIL ADDRESS: STREET 1: ONE GATEWAY CENTER STREET 2: SUITE 411 CITY: NEWTON STATE: MA ZIP: 02158 FORMER COMPANY: FORMER CONFORMED NAME: CLINICAL DATA INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALBERT IRA CENTRAL INDEX KEY: 0000923716 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 1304 SW 160TH AVE STREET 2: STE 209 CITY: FT LAUDERDALE STATE: FL ZIP: 33326 BUSINESS PHONE: 9543844801 MAIL ADDRESS: STREET 1: 1304 SW 160TH AVE STREET 2: STE 204 CITY: FT LAUDERDALE STATE: FL ZIP: 33326 SC 13D/A 1 SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------- SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* NOVITRON INTERNATIONAL, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 670088103 - -------------------------------------------------------------------------------- (CUSIP Number) Noah Klarish & Associates, P.C. 230 Park Avenue, 32nd Floor New York, NY 10169 (212) 973-1111 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) April 9, 1997 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP No. 670088103 - -------------------------------------------------------------------------------- 1 Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Ira Albert - -------------------------------------------------------------------------------- 2 Check the Appropriate Box If a Member of a Group* a. |_| b. |X| - -------------------------------------------------------------------------------- 3 SEC Use Only - -------------------------------------------------------------------------------- 4 Source of Funds* PF - -------------------------------------------------------------------------------- 5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- 7 Sole Voting Power Number of 133,667 (Includes 128,667 shares held by Shares Ira Albert Investment Associates, L.P.) Beneficially -------------------------------------------------------- Owned By 8 Shared Voting Power Each Reporting 0 Person -------------------------------------------------------- With 9 Sole Dispositive Power 164,933 (Includes 128,667 shares held by Albert Investment Associates, L.P. and 31,266 shares held by various accounts over which Mr. Albert has discretionary authority) -------------------------------------------------------- 10 Shared Dispositive Power 31,266 shares held by various accounts over which Mr. Albert has discretionary authority. - -------------------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 164,933 - -------------------------------------------------------------------------------- 12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* |_| - -------------------------------------------------------------------------------- 13 Percent of Class Represented By Amount in Row (11) 12.5% - -------------------------------------------------------------------------------- 14 Type of Reporting Person* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Item 1. Security and Issuer. This statement relates to the Common Stock, $.01 par value per share (the "Common Stock"), of Novitron International, Inc., a Delaware corporation (the "Issuer"). The Issuer maintains its principal executive office at One Gateway Center, Suite 411, Newton, Massachusetts 02158. Item 2. Identity and Background. (a) This statement is filed by (i) Ira Albert, an individual, with respect to shares of the Issuer's Common Stock held by him and with respect to shares of the Issuer's Common Stock held in investment accounts over which Mr. Albert has discretionary authority, and (ii) Albert Investment Associates, L.P., a Delaware limited partnership (the "Albert Partnership") with respect to shares of the Issuer's Common Stock held by it. Ira Albert and the Albert Partnership shall sometimes be collectively referred to herein as the "Reporting Person." (b) The Reporting Person filed an initial Schedule 13D for an event of November 12, 1996 (the "Initial Schedule"). Except to the extent set forth in this Amendment, the information in the Initial Schedule remains unchanged. Item 3. Source and Amount of Funds or Other Consideration. Ira Albert directly owns 5,000 shares of the Issuer's Common Stock for which he paid $16,087.50 Mr. Albert obtained the funds from his personal funds. Mr. Albert has discretionary authority over accounts which own 31,266 shares of the Issuer's Common Stock for which such accounts paid a total of $84,095 from the personal funds of the beneficial owners of such accounts. The Albert Partnership directly owns 128,667 shares of the Issuer's Common Stock for which it paid $371,924.50 from its working capital. Item 5. Interest in Securities of the Issuer. (a) The number of shares of the Issuer's Common Stock and the percentage of the outstanding shares (based upon 1,321,980 post split shares outstanding as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 1996) directly beneficially owned by each Reporting Person is as follows: Percentage of Name Number of Shares Outstanding Shares - ---- ---------------- ------------------ Ira Albert 5,000 0.4% Albert Partnership 128,667 9.7% Albert discretionary accounts 31,266 2.3% 3 (b) Mr. Albert has sole power to vote 133,667 shares of the Issuer's Common Stock and has sole power to dispose or to direct the disposition of 164,933 shares of the Issuer's Common Stock. (c) See Appendix I annexed hereto. 4 Signatures After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: April 11, 1997 /s/ Ira Albert -------------------------- Ira Albert ALBERT INVESTMENT ASSOCIATES, L.P. By: ALBERT INVESTMENT STRATEGIES, INC. By: /s/ Ira Albert ------------------------------ Ira Albert, President 5 APPENDIX 1 TRANSACTIONS IN NOVITRON INTERNATIONAL, INC. COMMON STOCK WITHIN THE PAST 60 DAYS All transactions were open market purchases and the commissions are included in the price of the shares. Albert Investment Associates, L.P. No. of Trade Shares Price Per Cost of Date Purchased Share Purchases ---- --------- ----- --------- 3/6/97 3,000 $3.17 $9,593.75 3/10/97 4,500 3.50 15,888.75 4/9/97 5,000 3.00 15,150.00 4/10/97 2,500 3.00 7,575.00 ------- ---------- $15,000 $48,207.50 6 -----END PRIVACY-ENHANCED MESSAGE-----